Article Versions Notes

Delfino D, Mori G, Rivetti C, Grigoletto A, Bizzotto G, Cavozzi C, Malatesta M, Cavazzini D, Pasut G, Percudani R. Actin-Resistant DNase1L2 as a Potential Therapeutics for CF Lung Disease. Biomolecules. 2021; 11(3):410. https://doi.org/10.3390/biom11030410

Delfino, Danila, Giulia Mori, Claudio Rivetti, Antonella Grigoletto, Gloria Bizzotto, Cristian Cavozzi, Marco Malatesta, Davide Cavazzini, Gianfranco Pasut, and Riccardo Percudani. 2021. "Actin-Resistant DNase1L2 as a Potential Therapeutics for CF Lung Disease" Biomolecules 11, no. 3: 410. https://doi.org/10.3390/biom11030410

Delfino, D., Mori, G., Rivetti, C., Grigoletto, A., Bizzotto, G., Cavozzi, C., Malatesta, M., Cavazzini, D., Pasut, G., & Percudani, R. (2021). Actin-Resistant DNase1L2 as a Potential Therapeutics for CF Lung Disease. Biomolecules, 11(3), 410. https://doi.org/10.3390/biom11030410